Based on the evolution of treatments and treatment strategies for IBD in the 2000s, we explored the use of corticosteroids in the first 5 years following diagnosis of IBD, and whether the pattern of corticosteroid use has changed with the introduction of advanced therapy and the introduction of biosimilars to TNF inhibitors. The gene discussed is TNF; the disease is inflammatory bowel disease.